Rating History for Supernus Pharmaceuticals (SUPN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for SUPN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/17/2025 David Amsellem Maintain Overweight
(N/A)		 65.00
(N/A)		  
 		   Details